CAS: 22427-39-0 Ginsenoside Rg1
video
CAS: 22427-39-0 Ginsenoside Rg1

CAS: 22427-39-0 Ginsenoside Rg1

Nimewo CAS: 22427-39-0
Fòmil: C42H72O14
Pwa molekilè: 801.01300
Pite: 97 pousan Min.
Pake: 5 g / 25 g / 100 g
Livrezon: DHL/FEDEX/UPS oswa pa lanmè

  • Livrezon atravè lemond
  • Kalite asirans
  • Sèvis Kliyan 24/7
Pwodwi Entwodiksyon

Entwodiksyon

Ginsenoside Rg1 pwoteje kont atrit atravè anpèchman diferansyasyon osteoclast. Anti-timè ajan, inibit NF-kB-depandan MMP-ekspresyon nan PMA (phorbol myristate acetate)-pwovoke envazyon selil timè.

Spesifikasyon CAS: 22427-39-0 Ginsenoside Rg1

ATIK

SPESIFIKASYON

Pwen k ap fonn

194-197 degre

tanperati depo.

Sele nan sèk, Sere nan frizè, anba -20 degre

fòm

pwòp

dansite

1.33±0.1 g/cm3

Pwen bouyi

898.5±65.0 degre

pka

12.91±0.70

Referans baz done CAS

22427-39-0(Referans baz done CAS)

Atik ki gen rapò akCAS: 22427-39-0 Ginsenoside Rg1


Efè Hepataprotective nan ginsenoside Rg1 - yon revizyon

Y Gao, S Chu, Z Zhang, N Chen - Journal of Etnopharmacology, 2017 - Elsevier


Efè neuroprotective milti-fè fas Ginsenoside Rg1 nan yon modèl sourit alzayme

F Fang, X Chen, T Huang, LF Lue, JS Luddy… - … ak Biophysica Acta (BBA …, 2012 - Elsevier


Efè anti-enflamatwa nan ginsenoside Rg1 ak metabolit li yo ginsenoside Rh1 ak 20 (S)-protopanaxatriol nan sourit ak kolit TNBS-induit

SY Lee, JJ Jeong, SH Eun, DH Kim - European journal of pharmacology, 2015 - Elsevier

Ginsenoside Rg1 anpeche ak trete maladi enflamatwa: Yon revizyon

Y Gao, J Li, J Wang, X Li, J Li, S Chu, L Li… - International …, 2020 - Elsevier

Baj popilè: cas: 22427-39-0 ginsenoside rg1, pri, sitasyon, rabè, nan stock, pou vann

Ou ka renmen tou

(0/10)

clearall